Anwendung von Biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen Covid-19-Pandemiea, b, c
Authors:
- Ludger KlimekLKLudger Klimek
- Oliver PfaarOPOliver Pfaar
- Margitta WormMWMargitta Worm
- Thomas EiweggerTEThomas Eiwegger
- Jan HagemannJHJan Hagemann
- Markus OllertMOMarkus Ollert
- Eva UntersmayrEUEva Untersmayr
- Karin Hoffmann-SommergruberKHKarin Hoffmann-Sommergruber
- Alessandra VultaggioAVAlessandra Vultaggio
- Ioana AgacheIAIoana Agache
- Sevim BavbekSBSevim Bavbek
- Apostolos BossiosABApostolos Bossios
- 24 June 2020
- journal article
- review article
- Published by Springer Nature in Allergo Journal
- Vol. 29 (4) , 14-27
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergyAllergy, 2017
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathologySeminars in Immunopathology, 2017
- Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected MiceCell Host & Microbe, 2016
- Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbationsJournal of Allergy and Clinical Immunology, 2015
- IL-4 Induced Innate CD8+ T Cells Control Persistent Viral InfectionPLOS Pathogens, 2015
- EAACI IG Biologicals task force paper on the use of biologic agents in allergic disordersAllergy, 2015
- How helminths go viralScience, 2014
- Innate and adaptive immune responses to viral infection and vaccinationCurrent Opinion in Virology, 2011
- Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City ChildrenNew England Journal of Medicine, 2011
- IL-4 Suppresses the Expression and the Replication of Hepatitis B Virus in the Hepatocellular Carcinoma Cell Line Hep3BThe Journal of Immunology, 2003